The role of the cylooxygenase pathway in nocicepti...[Semin Cell Dev Biol. 2006]

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: Semin Cell Dev Biol. 2006 Oct;17(5):544-54. Epub 2006 Sep 23. Links

The role of the cylooxygenase pathway in nociception and pain.

Bingham S, Beswick PJ, Blum DE, Gray NM, Chessell IP.

Neurology and Gastrointestinal CEDD, GlaxoSmithKline, Coldharbour Road, Harlow, Essex CM19 5AW, UK. Sharon.Bingham@gsk.com

Cycloxygenase (COX) pathways have long been targeted for the treatment of inflammatory pain, initially through the use of NSAIDs. With the demonstration of two major COX isoforms, COX-1 and COX-2, involved in the production of prostanoids, but with different distribution and regulation, selective COX-2 inhibitors have been developed. This review covers factors influencing COX enzyme activity, the role of their products in the development and maintenance of pain and discusses recent safety concerns of COX-2 inhibitors.

PMID: 17071117 [PubMed - indexed for MEDLINE]

Anti-inflammatory drugs in the 21st century. [Subcell Biochem. 2007]
Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib. [J Biol Chem. 2007]
Chemical and structural diversity in cyclooxygenase protein active sites. [Chem Biodivers. 2005]
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. [Curr Med Res Opin. 2006]
Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option? [Curr Pharm Des. 2007]
» See all Related Articles...

Display Show

The role of the cylooxygenase pathway in nociception and pain.

Related Articles